Zacks Research Lifts Earnings Estimates for Editas Medicine
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Stock analysts at Zacks Research upped their Q1 2025 EPS estimates for Editas Medicine in a report released on Wednesday, March 26th. Zacks Research analyst A. Chakraborty now anticipates that the company will earn ($0.63) per share for the quarter, up from their previous estimate of ($0.73). […]
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Stock analysts at Zacks Research upped their Q1 2025 EPS estimates for Editas Medicine in a report released on Wednesday, March 26th. Zacks Research analyst A. Chakraborty now anticipates that the company will earn ($0.63) per share for the quarter, up from their previous estimate of ($0.73). […]
